


<?phpxml version="1.0" encoding="utf-8"?>
<rss version="2.0" 
xmlns:content="http://purl.org/rss/1.0/modules/content/"
xmlns:wfw="http://wellformedweb.org/CommentAPI/"
xmlns:dc="http://purl.org/dc/elements/1.1/"
>
<channel>
<title>Dofollow Social Bookmarking Sites 2016 / biolabssss / Published News</title>
<link>http://www.bedsheets.ipt.pw</link>
<description>Your Source for Social News and Networking</description>
<pubDate>Sat, 24 Sep 2022 14:01:49 +0000</pubDate>
<language>en</language>
<item>
	<title><![CDATA[F(ab')2 Goat Anti-Human IgM (Heavy chain) Cross-Adsorbed Secondary Antibody (VRX-0217F) [FITC]]]></title>
	<link>http://www.bedsheets.ipt.pw/News/fab2-goat-anti-human-igm-heavy-chain-cross-adsorbed-secondary-antibody-vrx-0217f-fitc/</link>
	<source url="http://www.bedsheets.ipt.pw/News/fab2-goat-anti-human-igm-heavy-chain-cross-adsorbed-secondary-antibody-vrx-0217f-fitc/"><![CDATA[F(ab')2 Goat Anti-Human IgM (Heavy chain) Cross-Adsorbed Secondary Antibody (VRX-0217F) [FITC]]]></source>
	<description><![CDATA[Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic antibody to therapeutic antibody. We also provide professional custom antibody discovery, engineering and manufacturing services, including featured phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, sdAb, minibody etc.), antibody labeling, hybridoma/stable cell line development, virus protein production and GMP like manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 14:01:49 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/fab2-goat-anti-human-igm-heavy-chain-cross-adsorbed-secondary-antibody-vrx-0217f-fitc/</guid>
</item>

<item>
	<title><![CDATA[F(ab')2 Goat Anti-Human IgG (H+L) Cross-Adsorbed Secondary Antibody (VRX-0191F) [TRITC]]]></title>
	<link>http://www.bedsheets.ipt.pw/News/fab2-goat-anti-human-igg-hl-cross-adsorbed-secondary-antibody-vrx-0191f-tritc/</link>
	<source url="http://www.bedsheets.ipt.pw/News/fab2-goat-anti-human-igg-hl-cross-adsorbed-secondary-antibody-vrx-0191f-tritc/"><![CDATA[F(ab')2 Goat Anti-Human IgG (H+L) Cross-Adsorbed Secondary Antibody (VRX-0191F) [TRITC]]]></source>
	<description><![CDATA[Our cutting-edge Native™ Antibody discovery, Hyperdoma™ and Phage Display platforms allow the production of the most comprehensive list of virology recombinant antibody products. Our antibody products range from research use only antibody, diagnostic antibody to therapeutic antibody. We also provide professional custom antibody discovery, engineering and manufacturing services, including featured phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, sdAb, minibody etc.), antibody labeling, hybridoma/stable cell line development, virus protein production and GMP like manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 14:01:28 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/fab2-goat-anti-human-igg-hl-cross-adsorbed-secondary-antibody-vrx-0191f-tritc/</guid>
</item>

<item>
	<title><![CDATA[SRC scid mouse]]></title>
	<link>http://www.bedsheets.ipt.pw/News/src-scid-mouse/</link>
	<source url="http://www.bedsheets.ipt.pw/News/src-scid-mouse/"><![CDATA[SRC scid mouse]]></source>
	<description><![CDATA[Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients' requirements. Creative Biolabs is adhering the customer first and goal-oriented concept to serve our global clients with the most reliable and qualified results.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 14:01:04 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/src-scid-mouse/</guid>
</item>

<item>
	<title><![CDATA[spontaneous animal model]]></title>
	<link>http://www.bedsheets.ipt.pw/News/spontaneous-animal-model/</link>
	<source url="http://www.bedsheets.ipt.pw/News/spontaneous-animal-model/"><![CDATA[spontaneous animal model]]></source>
	<description><![CDATA[Creative Biolabs is one of the few companies who can offer integrated drug discovery services for clients all over the world. Talented and well-trained scientists are working closely with each other to realize the goal of our customers. To discover and develop the qualified medicines of tomorrow, our scientists are concentrating on every important aspect of the industry, especially for the drug discovery pipeline. Our services range from target identification and validation, hit identification, hit to lead, lead optimization to the investigational new drug (IND), and are subdivided into numerous details. Our dedicated scientists are able to undertake the entire discovery pipeline but also pleased to offer specific service based on clients' requirements. Creative Biolabs is adhering the customer first and goal-oriented concept to serve our global clients with the most reliable and qualified results.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 14:00:45 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/spontaneous-animal-model/</guid>
</item>

<item>
	<title><![CDATA[oligopotent stem cells]]></title>
	<link>http://www.bedsheets.ipt.pw/News/oligopotent-stem-cells/</link>
	<source url="http://www.bedsheets.ipt.pw/News/oligopotent-stem-cells/"><![CDATA[oligopotent stem cells]]></source>
	<description><![CDATA[Creative Biolabs provides high quality transcription-activator-like effector nuclease. Please contact us if you need more information. <br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 14:00:25 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/oligopotent-stem-cells/</guid>
</item>

<item>
	<title><![CDATA[iPSC facilitated drug discovery]]></title>
	<link>http://www.bedsheets.ipt.pw/News/ipsc-facilitated-drug-discovery/</link>
	<source url="http://www.bedsheets.ipt.pw/News/ipsc-facilitated-drug-discovery/"><![CDATA[iPSC facilitated drug discovery]]></source>
	<description><![CDATA[Creative Biolabs provides high quality transcription-activator-like effector nuclease. Please contact us if you need more information. <br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 14:00:04 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/ipsc-facilitated-drug-discovery/</guid>
</item>

<item>
	<title><![CDATA[Design-and-Synthesis-of-Haptens-for-Cadmium]]></title>
	<link>http://www.bedsheets.ipt.pw/News/design-and-synthesis-of-haptens-for-cadmium/</link>
	<source url="http://www.bedsheets.ipt.pw/News/design-and-synthesis-of-haptens-for-cadmium/"><![CDATA[Design-and-Synthesis-of-Haptens-for-Cadmium]]></source>
	<description><![CDATA[The successful preparation of cadmium haptens is essential for preparing specific antibodies, which are promising analytical tools for rapid and sensitive determination of metal ions in the environment. Creative Biolabs is leading in the field of haptens design and synthesis; we can provide the best-fit cadmium haptens for our customers all over the world.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:59:40 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/design-and-synthesis-of-haptens-for-cadmium/</guid>
</item>

<item>
	<title><![CDATA[Compound-specific-Haptens-for-β-agonists]]></title>
	<link>http://www.bedsheets.ipt.pw/News/compound-specific-haptens-for-b-agonists/</link>
	<source url="http://www.bedsheets.ipt.pw/News/compound-specific-haptens-for-b-agonists/"><![CDATA[Compound-specific-Haptens-for-β-agonists]]></source>
	<description><![CDATA[Creative Biolabs has an entrepreneurial team of highly-skilled and qualified experts in hapten design and small-molecule antibody development. The members have originated from a rich academic research background, bringing their experience into translation. We are very proud of providing high-quality, omnidirectional compound-specific hapten-based services targeting β-agonists to our valued clients to remove the difficulties of your projects.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:59:18 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/compound-specific-haptens-for-b-agonists/</guid>
</item>

<item>
	<title><![CDATA[Exploring Cancer Immunotherapies]]></title>
	<link>http://www.bedsheets.ipt.pw/News/exploring-cancer-immunotherapies/</link>
	<source url="http://www.bedsheets.ipt.pw/News/exploring-cancer-immunotherapies/"><![CDATA[Exploring Cancer Immunotherapies]]></source>
	<description><![CDATA[The development of cancer immunotherapies relies on an accurate understanding of the cellular composition and complex interactions between cells in the tumor microenvironment. To discover the secrets inside individual cells, Creative Biolabs developed a comprehensive suite of single cell omics solutions for your immuno oncology programs. We are dedicated to assisting you with exploring insights for novel cancer immunotherapies.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:58:52 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/exploring-cancer-immunotherapies/</guid>
</item>

<item>
	<title><![CDATA[scRNA-seq for TME]]></title>
	<link>http://www.bedsheets.ipt.pw/News/scrna-seq-for-tme/</link>
	<source url="http://www.bedsheets.ipt.pw/News/scrna-seq-for-tme/"><![CDATA[scRNA-seq for TME]]></source>
	<description><![CDATA[Tumor microenvironment (TME) is a multifaceted ecosystem with profound cellular heterogeneity, dynamics, and complex intercellular crosstalk. Although the acquisition of oncogene function and the loss of anti-oncogene function are the driving forces of tumorigenesis and development, TME, including extracellular matrix, peripheral matrix, signal molecules, infiltrating immune cells and other cell groups, is also considered to be the key to tumorigenesis and metastasis. Therefore, factors involved in the interaction of TME may provide new targets for diagnostic development and therapeutic intervention. Creative Biolabs offers fit-for-purpose single cell omics solutions to assist our clients to profile the tumor microenvironment.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:58:31 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/scrna-seq-for-tme/</guid>
</item>

<item>
	<title><![CDATA[sdAb for cell proliferation assay]]></title>
	<link>http://www.bedsheets.ipt.pw/News/sdab-for-cell-proliferation-assay/</link>
	<source url="http://www.bedsheets.ipt.pw/News/sdab-for-cell-proliferation-assay/"><![CDATA[sdAb for cell proliferation assay]]></source>
	<description><![CDATA[Single domain antibodies (sdAbs, or VHH) are the smallest antigen-binding units of antibodies, comprising either one variable domain or one engineered constant domain that solely facilitates target binding. They are popular as a novel class of proprietary therapeutic proteins containing unique structural and functional properties. At Creative Biolabs, we offer one-stop solutions for sdAb development and characterization to promote the identification of novel therapeutic sdAbs to meet your specific project demands.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:58:09 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/sdab-for-cell-proliferation-assay/</guid>
</item>

<item>
	<title><![CDATA[Recombinant F7 Protein aa 61-212 His Human origin]]></title>
	<link>http://www.bedsheets.ipt.pw/News/recombinant-f7-protein-aa-61-212-his-human-origin/</link>
	<source url="http://www.bedsheets.ipt.pw/News/recombinant-f7-protein-aa-61-212-his-human-origin/"><![CDATA[Recombinant F7 Protein aa 61-212 His Human origin]]></source>
	<description><![CDATA[Recombinant F7 Protein aa 61-212 His Human origin<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:57:49 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/recombinant-f7-protein-aa-61-212-his-human-origin/</guid>
</item>

<item>
	<title><![CDATA[Recombinant GDI1 Protein aa 1-447 His Human origin]]></title>
	<link>http://www.bedsheets.ipt.pw/News/recombinant-gdi1-protein-aa-1-447-his-human-origin/</link>
	<source url="http://www.bedsheets.ipt.pw/News/recombinant-gdi1-protein-aa-1-447-his-human-origin/"><![CDATA[Recombinant GDI1 Protein aa 1-447 His Human origin]]></source>
	<description><![CDATA[Recombinant GDI1 Protein aa 1-447 His Human origin<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:57:29 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/recombinant-gdi1-protein-aa-1-447-his-human-origin/</guid>
</item>

<item>
	<title><![CDATA[Ligand Design for Retinoic Acid Receptors (RAR)-targeting PROTAC]]></title>
	<link>http://www.bedsheets.ipt.pw/News/ligand-design-for-retinoic-acid-receptors-rar-targeting-protac/</link>
	<source url="http://www.bedsheets.ipt.pw/News/ligand-design-for-retinoic-acid-receptors-rar-targeting-protac/"><![CDATA[Ligand Design for Retinoic Acid Receptors (RAR)-targeting PROTAC]]></source>
	<description><![CDATA[Ligand Design for Retinoic Acid Receptors (RAR)-targeting PROTAC<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:57:12 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/ligand-design-for-retinoic-acid-receptors-rar-targeting-protac/</guid>
</item>

<item>
	<title><![CDATA[X-protein ligands]]></title>
	<link>http://www.bedsheets.ipt.pw/News/x-protein-ligands/</link>
	<source url="http://www.bedsheets.ipt.pw/News/x-protein-ligands/"><![CDATA[X-protein ligands]]></source>
	<description><![CDATA[X-protein ligands<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:56:51 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/x-protein-ligands/</guid>
</item>

<item>
	<title><![CDATA[non engineered phages]]></title>
	<link>http://www.bedsheets.ipt.pw/News/non-engineered-phages/</link>
	<source url="http://www.bedsheets.ipt.pw/News/non-engineered-phages/"><![CDATA[non engineered phages]]></source>
	<description><![CDATA[In the years spent in the research of phage-based applications, Creative Biolabs has acquired solid know-how in the field of in phage-based tools for pathogen detection. Our skilled experts have been established an unparalleled unmodified bacteriophages platform which includes phage typing, phage amplification, phage-mediated electrochemical-based methods, surfaces plasmon resonance-based sensor, and adenylate kinase techniques. These techniques are optimal for detection of interactions between phage and host bacteria.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:56:22 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/non-engineered-phages/</guid>
</item>

<item>
	<title><![CDATA[CelB reporter phage]]></title>
	<link>http://www.bedsheets.ipt.pw/News/celb-reporter-phage/</link>
	<source url="http://www.bedsheets.ipt.pw/News/celb-reporter-phage/"><![CDATA[CelB reporter phage]]></source>
	<description><![CDATA[Molecular cloning techniques makes it possible to engineer phage to carry a specific reporter gene, which provides an efficient alternative to native, unaltered phage particles for bacterial detection. Creative Biolabs is a biotechnology company who has rich experience in providing high-quality service in report phage engineering. We offer one-stop solutions to support you in all aspects of your report phage development.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:55:59 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/celb-reporter-phage/</guid>
</item>

<item>
	<title><![CDATA[immunoglobulin A antibody discovery services]]></title>
	<link>http://www.bedsheets.ipt.pw/News/immunoglobulin-a-antibody-discovery-services/</link>
	<source url="http://www.bedsheets.ipt.pw/News/immunoglobulin-a-antibody-discovery-services/"><![CDATA[immunoglobulin A antibody discovery services]]></source>
	<description><![CDATA[Creative Biolabs is a forward-looking company as well as a leading customer service provider in the field of IgA antibody development. Our scientists specialized in therapeutic antibody studies will work with you to develop the most appropriate strategy that will offer the most meaningful data for your research. We have experienced experts and advanced platforms that are able to provide excellent discovery services on therapeutic IgA antibodies.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:55:28 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/immunoglobulin-a-antibody-discovery-services/</guid>
</item>

<item>
	<title><![CDATA[IgE Antibody Development Services]]></title>
	<link>http://www.bedsheets.ipt.pw/News/ige-antibody-development-services/</link>
	<source url="http://www.bedsheets.ipt.pw/News/ige-antibody-development-services/"><![CDATA[IgE Antibody Development Services]]></source>
	<description><![CDATA[Since the commercial development of therapeutic monoclonal antibodies commenced in the early 1980s, the monoclonal antibodies have grown to become the most successful class of biotech drugs for the diagnosis and treatment against various diseases and infections. Besides the traditional IgG antibody, Creative Biolabs can help to develop Non-IgG therapeutic antibodies for our customers all over the world.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:54:27 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/ige-antibody-development-services/</guid>
</item>

<item>
	<title><![CDATA[HCV Core Protein Tetramer]]></title>
	<link>http://www.bedsheets.ipt.pw/News/hcv-core-protein-tetramer/</link>
	<source url="http://www.bedsheets.ipt.pw/News/hcv-core-protein-tetramer/"><![CDATA[HCV Core Protein Tetramer]]></source>
	<description><![CDATA[Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:54:06 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/hcv-core-protein-tetramer/</guid>
</item>

<item>
	<title><![CDATA[HA 2 Tetramer]]></title>
	<link>http://www.bedsheets.ipt.pw/News/ha-2-tetramer/</link>
	<source url="http://www.bedsheets.ipt.pw/News/ha-2-tetramer/"><![CDATA[HA 2 Tetramer]]></source>
	<description><![CDATA[Our cutting-edge hybridoma development and phage display platforms allow the production of the most comprehensive list of recombinant antibody products and extensive service portfolio at the most competitive price. Our products range from antibody / peptide libraries, Biosimilar cell lines, Chimeric antigen receptor (CAR) products, antibody-drug conjugates (ADCs) to engineered antibodies such as therapeutic antibodies, single-domain antibodies, bispecific antibodies and intrabodies. We also provide professional custom antibody discovery and engineering services, featuring phage display library construction, antibody humanization, chimerization, engineered antibody production (Fab, scFc, tribody, bispecific antibody, SdAb, minibody, etc.), antibody labeling, hybridoma/stable cell line development, membrane protein production and cGMP-manufacturing which enable larger scale antibody production for development of animal-based assays and clinical trials.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:53:47 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/ha-2-tetramer/</guid>
</item>

<item>
	<title><![CDATA[Acid Sphingomyelinase Inhibitors for NAFLD Treatment]]></title>
	<link>http://www.bedsheets.ipt.pw/News/acid-sphingomyelinase-inhibitors-for-nafld-treatment/</link>
	<source url="http://www.bedsheets.ipt.pw/News/acid-sphingomyelinase-inhibitors-for-nafld-treatment/"><![CDATA[Acid Sphingomyelinase Inhibitors for NAFLD Treatment]]></source>
	<description><![CDATA[Creative Biolabs is a leading service provider of drug discovery & development with great dedication to accelerating non-alcoholic steatohepatitis (NASH) drug development. With more than 10 years of experience in antibody engineering and drug development, we can be the most reliable and qualified contract manufacturer for your NASH research project. Regardless of the stage, scope or scale of your project, we can provide you with customized solutions and high-quality services for NASH's early overcoming.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:53:28 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/acid-sphingomyelinase-inhibitors-for-nafld-treatment/</guid>
</item>

<item>
	<title><![CDATA[Haploinsufficiency Profiling for NAFLD]]></title>
	<link>http://www.bedsheets.ipt.pw/News/haploinsufficiency-profiling-for-nafld/</link>
	<source url="http://www.bedsheets.ipt.pw/News/haploinsufficiency-profiling-for-nafld/"><![CDATA[Haploinsufficiency Profiling for NAFLD]]></source>
	<description><![CDATA[Creative Biolabs is a leading service provider of drug discovery & development with great dedication to accelerating non-alcoholic steatohepatitis (NASH) drug development. With more than 10 years of experience in antibody engineering and drug development, we can be the most reliable and qualified contract manufacturer for your NASH research project. Regardless of the stage, scope or scale of your project, we can provide you with customized solutions and high-quality services for NASH's early overcoming.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:53:08 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/haploinsufficiency-profiling-for-nafld/</guid>
</item>

<item>
	<title><![CDATA[IVT system IVT system]]></title>
	<link>http://www.bedsheets.ipt.pw/News/ivt-system-ivt-system/</link>
	<source url="http://www.bedsheets.ipt.pw/News/ivt-system-ivt-system/"><![CDATA[IVT system IVT system]]></source>
	<description><![CDATA[During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:52:46 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/ivt-system-ivt-system/</guid>
</item>

<item>
	<title><![CDATA[mRNA Kits mRNA Kits]]></title>
	<link>http://www.bedsheets.ipt.pw/News/mrna-kits-mrna-kits/</link>
	<source url="http://www.bedsheets.ipt.pw/News/mrna-kits-mrna-kits/"><![CDATA[mRNA Kits mRNA Kits]]></source>
	<description><![CDATA[During developments of mRNA therapeutics, the stability and translation efficiency remains two pivotal issues at early stage and may have influences throughout the overall development processes even the large scale manufacture and they need to be addressed as early as possible. To this end, Creative Biolabs has developed a comprehensive platform enabling optimization of mRNA synthesis, modification, and delivery method.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:52:23 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/mrna-kits-mrna-kits/</guid>
</item>

<item>
	<title><![CDATA[anti sfrs10 antibody]]></title>
	<link>http://www.bedsheets.ipt.pw/News/anti-sfrs10-antibody/</link>
	<source url="http://www.bedsheets.ipt.pw/News/anti-sfrs10-antibody/"><![CDATA[anti sfrs10 antibody]]></source>
	<description><![CDATA[Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and microorganisms, focusing on the research needs of different models of biological antibodies and becoming a direct supplier of products.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:51:52 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/anti-sfrs10-antibody/</guid>
</item>

<item>
	<title><![CDATA[lyophilized tpp2 antibody]]></title>
	<link>http://www.bedsheets.ipt.pw/News/lyophilized-tpp2-antibody/</link>
	<source url="http://www.bedsheets.ipt.pw/News/lyophilized-tpp2-antibody/"><![CDATA[lyophilized tpp2 antibody]]></source>
	<description><![CDATA[Creative Biolabs was established as a biotechnology company specializing in developing and production of antibodies and also a service provider for customized products and relevant services. The company was founded by a group of scientists and entrepreneurs who are committed to changing the traditional antibody model and establishing a new service platform. Employees at Creative Biolabs are composed of elites (Masters & PhD) from top universities worldwide. As an antibody customization service provider, we are dedicated to the research and development of antibodies to animals, plants and microorganisms, focusing on the research needs of different models of biological antibodies and becoming a direct supplier of products.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:51:29 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/lyophilized-tpp2-antibody/</guid>
</item>

<item>
	<title><![CDATA[microfluidic biomarkers measurement]]></title>
	<link>http://www.bedsheets.ipt.pw/News/microfluidic-biomarkers-measurement/</link>
	<source url="http://www.bedsheets.ipt.pw/News/microfluidic-biomarkers-measurement/"><![CDATA[microfluidic biomarkers measurement]]></source>
	<description><![CDATA[Creative Biolabs focuses on the recent advances of biomarker identification using microfluidic techniques for basic research or clinical diagnosis. Our experts have developed rapidly adaptable lab-on-chip platforms to support the low-cost and straightforward measurement of biomarkers and allow the limited volumes of samples to be analyzed on chip-scale devices with fluidic microchannels.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:51:06 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/microfluidic-biomarkers-measurement/</guid>
</item>

<item>
	<title><![CDATA[microfluidic recirculated]]></title>
	<link>http://www.bedsheets.ipt.pw/News/microfluidic-recirculated/</link>
	<source url="http://www.bedsheets.ipt.pw/News/microfluidic-recirculated/"><![CDATA[microfluidic recirculated]]></source>
	<description><![CDATA[Microfluidics offers technology to enable the miniaturization of biological assays, significantly improving the analysis efficiency of samples. The micro-channels are generally small in cross-sectional area and can run many samples in parallel. This parallelization, in conjunction with the small volumes required for a given test, facilitates high-throughput analysis. Creative Biolabs is dedicated to establishing the most exquisite microfluidic platform for our clients and the one-stop microfluidic solutions can provide comprehensive technical support for advancing our clients' projects.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:50:16 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/microfluidic-recirculated/</guid>
</item>

<item>
	<title><![CDATA[Microbial Purifying Services]]></title>
	<link>http://www.bedsheets.ipt.pw/News/microbial-purifying-services/</link>
	<source url="http://www.bedsheets.ipt.pw/News/microbial-purifying-services/"><![CDATA[Microbial Purifying Services]]></source>
	<description><![CDATA[Microbial Purifying Services<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:49:26 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/microbial-purifying-services/</guid>
</item>

<item>
	<title><![CDATA[Metatranscriptomics Profiling]]></title>
	<link>http://www.bedsheets.ipt.pw/News/metatranscriptomics-profiling/</link>
	<source url="http://www.bedsheets.ipt.pw/News/metatranscriptomics-profiling/"><![CDATA[Metatranscriptomics Profiling]]></source>
	<description><![CDATA[Metatranscriptomics Profiling<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:49:08 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/metatranscriptomics-profiling/</guid>
</item>

<item>
	<title><![CDATA[application of liposomes in drug delivery]]></title>
	<link>http://www.bedsheets.ipt.pw/News/application-of-liposomes-in-drug-delivery/</link>
	<source url="http://www.bedsheets.ipt.pw/News/application-of-liposomes-in-drug-delivery/"><![CDATA[application of liposomes in drug delivery]]></source>
	<description><![CDATA[Since the inception of Creative Biolabs, our research and service capacity has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 1-III clinical trials.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:48:47 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/application-of-liposomes-in-drug-delivery/</guid>
</item>

<item>
	<title><![CDATA[Azide-Doxorubicin Liposome (PEGylated)]]></title>
	<link>http://www.bedsheets.ipt.pw/News/azide-doxorubicin-liposome-pegylated/</link>
	<source url="http://www.bedsheets.ipt.pw/News/azide-doxorubicin-liposome-pegylated/"><![CDATA[Azide-Doxorubicin Liposome (PEGylated)]]></source>
	<description><![CDATA[Since the inception of Creative Biolabs, our research and service capacity has expanded to the entire new drug discovery and development pipeline, including early discovery, preclinical testing, process development, cGMP manufacturing, phase 1-III clinical trials.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:48:26 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/azide-doxorubicin-liposome-pegylated/</guid>
</item>

<item>
	<title><![CDATA[In Vivo Model Development for PD-1 inhibitors]]></title>
	<link>http://www.bedsheets.ipt.pw/News/in-vivo-model-development-for-pd-1-inhibitors/</link>
	<source url="http://www.bedsheets.ipt.pw/News/in-vivo-model-development-for-pd-1-inhibitors/"><![CDATA[In Vivo Model Development for PD-1 inhibitors]]></source>
	<description><![CDATA[Creative Biolabs provides a full range of immune checkpoint antibody development services from antibody discovery to preclinical trials in a timely and cost-effective manner. Our featured services include monoclonal antibody development, phage display antibody library construction and screening, antibody humanization, antibody production, bispecific antibody development, and so on. Besides, we also support immune checkpoint small molecule drug development and immune checkpoint assays to meet your specific requirement. Moreover, we also provide a series of high-quality immune checkpoint-related products to support your immune checkpoint research and drug discovery projects.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:48:03 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/in-vivo-model-development-for-pd-1-inhibitors/</guid>
</item>

<item>
	<title><![CDATA[TIM-3 drug EDR assay]]></title>
	<link>http://www.bedsheets.ipt.pw/News/tim-3-drug-edr-assay/</link>
	<source url="http://www.bedsheets.ipt.pw/News/tim-3-drug-edr-assay/"><![CDATA[TIM-3 drug EDR assay]]></source>
	<description><![CDATA[With our state-of-the-art technology and industry-leading expertise, Creative Biolabs has developed a comprehensive range of assays that fully support our clients' immune checkpoint blocker resistance studies. Leveraging the wealth of information that we have on drug resistance studies, we can help our clients with their studies and provide suggested assays to test.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:47:12 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/tim-3-drug-edr-assay/</guid>
</item>

<item>
	<title><![CDATA[ARMC4 pU6 shRNA]]></title>
	<link>http://www.bedsheets.ipt.pw/News/armc4-pu6-shrna/</link>
	<source url="http://www.bedsheets.ipt.pw/News/armc4-pu6-shrna/"><![CDATA[ARMC4 pU6 shRNA]]></source>
	<description><![CDATA[Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and design at the very early stage of development, design and application of in vitro and in vivo assays for proof-of-concept studies, comprehensive development of full set of assays for measuring potency and safety, from which the information should be clarified to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA). <br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:46:54 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/armc4-pu6-shrna/</guid>
</item>

<item>
	<title><![CDATA[MICALCL pU6 shRNA]]></title>
	<link>http://www.bedsheets.ipt.pw/News/micalcl-pu6-shrna/</link>
	<source url="http://www.bedsheets.ipt.pw/News/micalcl-pu6-shrna/"><![CDATA[MICALCL pU6 shRNA]]></source>
	<description><![CDATA[Gene therapy is an experimental technique that uses genes to treat or prevent disease. In the future, this technique may allow treating a disorder by inserting a gene into a patient's cells instead of using drugs or surgery. There are numerous ongoing researches of which the focus is testing several approaches to gene therapy. Although gene therapy is a promising treatment scenario for a number of diseases, including inherited disorders, some types of cancer, and certain viral infections, there is still a number of obstacles to be overcome in terms of the therapeutic modality selection and design at the very early stage of development, design and application of in vitro and in vivo assays for proof-of-concept studies, comprehensive development of full set of assays for measuring potency and safety, from which the information should be clarified to support an Investigational New Drug Application (IND) or a Biologics License Application (BLA). <br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:46:34 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/micalcl-pu6-shrna/</guid>
</item>

<item>
	<title><![CDATA[Galacto-N-biose]]></title>
	<link>http://www.bedsheets.ipt.pw/News/galacto-n-biose/</link>
	<source url="http://www.bedsheets.ipt.pw/News/galacto-n-biose/"><![CDATA[Galacto-N-biose]]></source>
	<description><![CDATA[Therapeutic glycoproteins have become the fastest growing fields in the pharmaceutical industry. Creative Biolabs is a leading customer service provider in the field of therapeutic glycoprotein development. Equipped with the latest world-leading technology platforms and professional scientific staff, Creative Biolabs is dedicated to providing high-quality glycoprotein production and corresponding analysis service. Our seasoned scientists are more than happy to share our cutting-edge experience in therapeutic glycoprotein development to meet every unique requirement of our clients.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:45:40 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/galacto-n-biose/</guid>
</item>

<item>
	<title><![CDATA[Galactosyl isomaltol]]></title>
	<link>http://www.bedsheets.ipt.pw/News/galactosyl-isomaltol/</link>
	<source url="http://www.bedsheets.ipt.pw/News/galactosyl-isomaltol/"><![CDATA[Galactosyl isomaltol]]></source>
	<description><![CDATA[Therapeutic glycoproteins have become the fastest growing fields in the pharmaceutical industry. Creative Biolabs is a leading customer service provider in the field of therapeutic glycoprotein development. Equipped with the latest world-leading technology platforms and professional scientific staff, Creative Biolabs is dedicated to providing high-quality glycoprotein production and corresponding analysis service. Our seasoned scientists are more than happy to share our cutting-edge experience in therapeutic glycoprotein development to meet every unique requirement of our clients.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:45:22 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/galactosyl-isomaltol/</guid>
</item>

<item>
	<title><![CDATA[gammadelta T Cell Therapy Development for Hepatitis C Virus Infections]]></title>
	<link>http://www.bedsheets.ipt.pw/News/gammadelta-t-cell-therapy-development-for-hepatitis-c-virus-infections/</link>
	<source url="http://www.bedsheets.ipt.pw/News/gammadelta-t-cell-therapy-development-for-hepatitis-c-virus-infections/"><![CDATA[gammadelta T Cell Therapy Development for Hepatitis C Virus Infections]]></source>
	<description><![CDATA[γδ T cells are one type of innate immune cells, and their functions include cytotoxicity, cytokine secretion, antigen presentation, and crosstalk with other immune cells. In the process of infection, autoimmune reaction, or tumor development, γδ T cells are activated to stimulate, regulate, or even suppress the immune response. As a leader in the research of γδ T cells, Creative Biolabs is driven to provide comprehensive γδ T cells development and engineering services to promote their clinical application in HCV treatment.<br /> ]]></description>
	<pubDate>Sat, 24 Sep 2022 13:45:03 +0000</pubDate>
	<author>biolabssss</author>
	<category>News</category>
	<votes>1</votes>
	<guid>http://www.bedsheets.ipt.pw/News/gammadelta-t-cell-therapy-development-for-hepatitis-c-virus-infections/</guid>
</item>

</channel>
</rss>
